查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
精准医疗时代的医学事务－驾驭复杂性，推动进步：专家问答
市场调查报告书
商品编码
1726420

精准医疗时代的医学事务－驾驭复杂性，推动进步：专家问答

Expert Q&A: Medical Affairs in the Precision Medicine Era - Navigating Complexity, Enabling Progress
出版日期: | 出版商: FirstWord Group | 英文 | 商品交期: 最快1-2个工作天内

价格
简介目录

医学事务团队在精准医疗领域，在弥合尖端科学与临床实践之间的差距方面发挥着关键作用。他们不仅是数据共享者，还与研究人员和医疗保健专业人员 (HCP) 密切合作，整合基因组学、生物标记和临床洞察，将复杂的分子数据转化为服务于不同患者群体的个人化治疗策略。

FirstWord 访问了艾伯维肿瘤全球和美国医学事务副总裁 Svetlana Kobina，探讨了医学事务在精准医疗中不断演变的角色、其中蕴含的机会和课题，以及艾伯维如何努力改善患者治疗效果。

关键问题

  • 精准医疗如何改变了艾伯维医学事务部门的角色？
  • 管理和分析精准医疗所需的大量资料集面临的最大课题是什么？
  • 医学事务如何促进精准医疗领域研究人员、医疗专业人员 (HCP) 与监管机构之间的合作？
  • 您使用哪些策略有效地将复杂的科学数据传达给 HCP 和患者？
  • 精准医疗的开发与实施面临哪些主要的监管课题？
  • 艾伯维 (AbbVie) 如何解决与精准医疗相关的伦理问题，例如可近性和可负担性？
  • 艾伯维 (AbbVie) 如何确保 HCP 接受适当的培训，以便在临床实践中实施精准医疗？
  • 医学事务专业人员在临床医师的持续教育与训练中扮演什么角色？
  • 精准医疗的未来发展方向为何？艾伯维 (AbbVie) 如何为此做好准备？

方法论：

檔案报告是基于独立而简洁的分析，这些分析源自于专有的产业研究以及对产业思想领袖的深入访谈。我们的报告深入分析了製药公司主管需要了解的关键发展和市场趋势，以应对未来的机会和课题。每份报告的重点都基于对二手文献的回顾和已发现的知识差距。基于这些初步研究，我们制定了基于证据、专家意见的讨论指南，以确保我们的研究能够解答最重要的问题。此外，我们采用严格的筛选标准，以确保受访者有足够的经验、知识和资格就该主题发表意见。

我们的报告有何独特之处？

FirstWord Reports 是值得信赖的行业领导者，专注于製药业，为生物製药专业人士和决策者提供深入、可操作的洞察。我们深厚的行业知识使我们能够为您提供相关且有价值的洞察，帮助您掌握新兴趋势并有效应对复杂课题。凭藉广泛的研究以及来自领先专家和关键意见领袖的独立、公正的见解，我们的报告能够为您提供所需的准确性和可靠性。独家访谈和数据，以及持续的市场监测，让您可以全面洞察市场动态。我们的报告涵盖 40 多个活跃疾病领域，包含 KOL 洞察和定量医生调查等医生情报，以及行业专家对医疗事务、数位健康、销售与行销、市场准入及其他领域问题的看法，助您做出更明智的数据驱动决策，在快速变化的行业中保持竞争力。

简介目录

Medical affairs teams are a crucial link between advanced science and clinical practice in precision medicine. Not just data sharers, they integrate genomic, biomarker and clinical insights in close collaboration with researchers and healthcare professionals (HCPs) to translate complex molecular data into personalized treatment strategies to benefit diverse patient populations.

FirstWord spoke with Svetlana Kobina, vice president of oncology global and US medical affairs at AbbVie, about how the role of medical affairs is evolving in precision medicine, the associated opportunities and challenges, and how AbbVie is addressing them to enhance patient outcomes.

Key Questions Answered:

  • How has precision medicine changed the role of medical affairs at AbbVie?
  • What are the biggest challenges in managing and analysing the large datasets required for precision medicine?
  • How does medical affairs facilitate collaboration among researchers, HCPs and regulatory bodies in precision medicine?
  • What strategies do you use to effectively communicate complex scientific data to HCPs and patients?
  • What are the key regulatory challenges in developing and implementing precision medicines?
  • How does AbbVie address ethical concerns related to precision medicine, such as accessibility and affordability?
  • How does AbbVie ensure HCPs are adequately trained to implement precision medicine in clinical practice?
  • What role do medical affairs professionals play in ongoing education and training for clinicians?
  • What future trends do you foresee in precision medicine, and how is AbbVie preparing for them?

Methodology:

Dossier reports are developed from independent and concise analysis derived from original industry surveys and in-depth interviews with industry thought leaders. Reports analyse in detail significant developments and market trends that pharma executives need to understand if they are to manage the opportunities and challenges that lie ahead. The focus of each report is defined by a review of the secondary literature and any knowledge gaps identified. Based on this initial research, an evidence-based and expert-informed discussion guide is developed to ensure the research answers the most critical questions. Additionally, robust screening criteria are established to ensure that those interviewed are qualified in terms of their experience, knowledge and stature to speak on the topic.

What makes our reports different?

FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.